Fortress Biotech, Inc.

Fortress Biotech, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Fortress Biotech, Inc. could be a weak company given it's low Piotroski F-score. Fortress Biotech, Inc. is not a good value stock. Fortress Biotech, Inc. is a mediocre stock to choose.
Log in to see more information.
Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and...
FBIO Fundamental Data by TradingView

News

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Globe Newswire SCOTTSDALE, Ariz., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ( Journey Medical or the Company ) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...\n more…

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Globe Newswire MIAMI, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) ( Fortress ), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term...\n more…

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Globe Newswire SCOTTSDALE, Ariz., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation ( Journey Medical or the Company ) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily...\n more…

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Globe Newswire WALTHAM, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ( Checkpoint ) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that...\n more…

Fortress Biotech (NASDAQ:FBIO) Shares Pass Above 200-Day Moving Average of $1.90
Fortress Biotech (NASDAQ:FBIO) Shares Pass Above 200-Day Moving Average of $1.90

Ticker Report Fortress Biotech, Inc. (NASDAQ:FBIO - Get Free Report) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.90 and traded...\n more…

Fortress Biotech (NASDAQ:FBIO) Stock Passes Above 200-Day Moving Average of $1.90
Fortress Biotech (NASDAQ:FBIO) Stock Passes Above 200-Day Moving Average of $1.90

Zolmax Fortress Biotech, Inc. (NASDAQ:FBIO - Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.90 and traded as high as...\n more…